Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 19, 2021

SELL
$83.5 - $98.47 $589,092 - $694,705
-7,055 Closed
0 $0
Q2 2020

Jul 29, 2020

SELL
$80.93 - $91.1 $13,353 - $15,031
-165 Reduced 2.29%
7,055 $616,000
Q1 2020

Apr 28, 2020

SELL
$70.67 - $99.01 $36,395 - $50,990
-515 Reduced 6.66%
7,220 $595,000
Q4 2019

Feb 06, 2020

BUY
$84.35 - $95.37 $21,509 - $24,319
255 Added 3.41%
7,735 $732,000
Q3 2019

Nov 05, 2019

BUY
$85.54 - $94.26 $68,432 - $75,408
800 Added 11.98%
7,480 $650,000
Q2 2019

Aug 05, 2019

SELL
$75.4 - $92.8 $7,540 - $9,280
-100 Reduced 1.47%
6,680 $610,000
Q1 2019

May 06, 2019

SELL
$75.32 - $86.15 $701,982 - $802,918
-9,320 Reduced 57.89%
6,780 $652,000
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $1.19 Million - $1.32 Million
16,100 New
16,100 $1.38 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Slate Stone Wealth, LLC Portfolio

Follow Slate Stone Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.